4N85
Crystal structure of human transthyretin
Summary for 4N85
| Entry DOI | 10.2210/pdb4n85/pdb |
| Related | 4N86 4N87 |
| Descriptor | Transthyretin, CALCIUM ION (3 entities in total) |
| Functional Keywords | thyroxine binding, transport protein |
| Biological source | Homo sapiens (human) |
| Cellular location | Secreted: P02766 |
| Total number of polymer chains | 2 |
| Total formula weight | 34741.27 |
| Authors | Yokoyama, T.,Kosaka, Y.,Mizuguchi, M. (deposition date: 2013-10-17, release date: 2014-02-19, Last modification date: 2023-11-08) |
| Primary citation | Yokoyama, T.,Kosaka, Y.,Mizuguchi, M. Crystal structures of human transthyretin complexed with glabridin J.Med.Chem., 57:1090-1096, 2014 Cited by PubMed Abstract: Transthyretin (TTR) is a plasma protein implicated in human amyloid diseases. Several small molecules that bind to the thyroxine-binding site of TTR have been shown to stabilize the TTR tetramer and to inhibit amyloid fibril formation of TTR. Herein, we demonstrated that glabridin (Glab), a prenylated isoflavan isolated from Glycyrrhiza glabra L., inhibited aggregation of TTR in a thioflavin assay. The TTR-Glab complex structure revealed a novel binding mode including a CH-π interaction with A108 and a hydrogen bond with K15. A structural comparison with the wild type-apo structure revealed that the CH-π interaction with A108 was strengthened by the induced-fit conformational change upon Glab binding. Furthermore, the binding of Glab induced a rotation of the T119 side chain, and the inclusion of a water molecule, leading to stabilization of the dimer-dimer interface. These results demonstrate that Glab is a novel inhibitor of TTR fibrillization and suggest the molecular mechanism by which Glab binding stabilizes the tetramer. PubMed: 24422526DOI: 10.1021/jm401832j PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (1.6 Å) |
Structure validation
Download full validation report






